vinpocetine has been researched along with Inflammation in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (57.14) | 24.3611 |
2020's | 5 (35.71) | 2.80 |
Authors | Studies |
---|---|
Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
Bucki, A; Chłoń-Rzepa, G; Funk, P; Gawalska, A; Lemrová, B; Nowak, B; Pawłowski, M; Pociecha, K; Ručilová, V; Soural, M; Świerczek, A; Vanda, D; Wyska, E; Zadrożna, M; Zajdel, P | 1 |
Kulkarni, GT; Luhach, K; Sharma, B; Singh, VP | 2 |
Cao, Y; Chen, S; Shao, L; Zhang, P | 1 |
Hsu, CG; Li, D; Mohan, A; Shi, H; Yan, C; Zhang, C | 1 |
Chen, J; Gong, Z; Hao, J; Liu, S; Ma, X; Shi, FD; Wei, C; Yan, C; Yao, Y; Zang, D; Zhang, F | 1 |
Adeluwa, TP; Akinyede, AA; Ishola, IO; Micah, C | 1 |
Alves-Filho, JC; Bernardy, CCF; Borghi, SM; Casagrande, R; Cunha, FQ; Cunha, TM; Domiciano, TP; Fattori, V; Lourenco-Gonzalez, Y; Rossaneis, AC; Verri, WA; Zaninelli, TH | 1 |
Abdelsalam, RM; Zaki, HF | 1 |
Fan, F; Li, H; Li, S; Lu, Y; Peng, W; Wang, K; Xu, Y; Zhuang, J | 1 |
Medina, AE | 1 |
Li, QY; Lu, CZ; Ma, CG; Xiao, BG; Yu, JZ; Zhao, YY | 1 |
Banner, KH; Page, CP | 1 |
1 trial(s) available for vinpocetine and Inflammation
Article | Year |
---|---|
Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury.
Topics: Adult; Anti-Inflammatory Agents; Antioxidants; Cognition; Cognitive Dysfunction; Cytokines; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Inflammation; Male; Mental Status and Dementia Tests; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Oxidants; Oxidative Stress; Radiation Injuries; Random Allocation; Toll-Like Receptors; Vinca Alkaloids | 2021 |
13 other study(ies) available for vinpocetine and Inflammation
Article | Year |
---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases.
Topics: Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Cyclic Nucleotide Phosphodiesterases, Type 7; Disease Models, Animal; Female; Humans; Imidazoles; Inflammation; Male; Mice, Inbred BALB C; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Pyridines; Rats, Wistar | 2021 |
Vinpocetine ameliorates developmental hyperserotonemia induced behavioral and biochemical changes: role of neuronal function, inflammation, and oxidative stress.
Topics: Animals; Autism Spectrum Disorder; Biomarkers; Brain-Derived Neurotrophic Factor; Inflammation; Interleukin-10; Interleukin-6; Oxidative Stress; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 2022 |
Vinpocetine protects against the development of experimental abdominal aortic aneurysms.
Topics: Animals; Aortic Aneurysm, Abdominal; Cells, Cultured; Dilatation, Pathologic; Disease Progression; Elastin; Inflammation; Macrophages; Mice, Inbred C57BL; Myocytes, Smooth Muscle; NF-kappa B; Protective Agents; Proteoglycans; Proteolysis; Vinca Alkaloids | 2020 |
Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress.
Topics: Animals; Autism Spectrum Disorder; Behavior, Animal; Biomarkers; Disease Models, Animal; Doublecortin Protein; Female; Inflammation; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Valproic Acid; Vinca Alkaloids | 2021 |
Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.
Topics: Adult; Aged; Brain Ischemia; C-Reactive Protein; Cytokines; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Inflammation; Leukocytes, Mononuclear; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroprotective Agents; NF-kappa B; RNA, Messenger; Statistics, Nonparametric; Stroke; Time Factors; Vinca Alkaloids | 2018 |
Novel action of vinpocetine in the prevention of paraquat-induced parkinsonism in mice: involvement of oxidative stress and neuroinflammation.
Topics: Animals; Glutathione; Herbicides; Inflammation; Male; Mice; Motor Activity; Neuroprotective Agents; Oxidative Stress; Paraquat; Parkinson Disease, Secondary; Rotarod Performance Test; Superoxide Dismutase; Vinca Alkaloids | 2018 |
Repurposing of the Nootropic Drug Vinpocetine as an Analgesic and Anti-Inflammatory Agent: Evidence in a Mouse Model of Superoxide Anion-Triggered Inflammation.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Drug Repositioning; Edema; Heme Oxygenase-1; Hyperalgesia; Inflammation; Male; Membrane Proteins; Mice; NF-E2-Related Factor 2; NF-kappa B; Nootropic Agents; Oxidative Stress; Reactive Oxygen Species; Superoxides; Vinca Alkaloids | 2019 |
Vinpocetine protects liver against ischemia-reperfusion injury.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers, Pharmacological; Curcumin; Cytokines; Glutathione; Inflammation; Interleukin-10; Interleukin-1beta; Interleukin-6; L-Lactate Dehydrogenase; Liver; Male; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury; Transaminases; Vinca Alkaloids | 2013 |
Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cyclic Nucleotide Phosphodiesterases, Type 1; Disease Models, Animal; Disease Progression; Foam Cells; Humans; I-kappa B Proteins; Inflammation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Monocytes; NF-kappa B; Oxidative Stress; Phosphorylation; Plaque, Atherosclerotic; Proto-Oncogene Proteins c-akt; Signal Transduction; Vinca Alkaloids | 2013 |
Vinpocetine as a potent antiinflammatory agent.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; I-kappa B Kinase; Inflammation; Models, Biological; Neurodegenerative Diseases; Neuronal Plasticity; Nootropic Agents; Phosphodiesterase Inhibitors; Vinca Alkaloids | 2010 |
TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation.
Topics: Animals; Cell Death; Cell Line, Transformed; Cells, Cultured; Cerebral Cortex; Down-Regulation; Inflammation; Ligands; Male; Mice; Mice, Inbred C57BL; Microglia; Neuroprotective Agents; Receptors, GABA; Up-Regulation; Vinca Alkaloids | 2011 |
Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs.
Topics: 1-Methyl-3-isobutylxanthine; Allergens; Animals; Guinea Pigs; Inflammation; Male; Ovalbumin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pulmonary Alveoli; Vinca Alkaloids | 1995 |